% ============================================================================
% CONSTRAINT STORY: faint_blue_neural_bifurcation
% ============================================================================
% Version: 1.0 (Deferential Realism Core + Directionality + Boltzmann + Network)
% Logic: 6.0 (Indexed Tuple P,T,E,S + Sigmoid f(d) + Coupling + Purity + Network)
% Generated: 2026-02-26
% Status: [ACTIVE]
% ============================================================================

:- module(constraint_faint_blue_neural_bifurcation, []).

:- use_module(constraint_indexing).
:- use_module(domain_priors).
:- use_module(narrative_ontology).

% --- Constraint Identity Rule (DP-001: ε-Invariance) ---
% Each constraint story must have a single, stable base extractiveness (ε).
% If changing the observable used to evaluate this constraint would change ε,
% you are looking at two distinct constraints. Write separate .pl files for
% each, link them with affects_constraint/2, and document the relationship
% in both files' narrative context sections.
%
% The context tuple is CLOSED at arity 4: (P, T, E, S).
% Do not add measurement_basis, beneficiary/victim, or any other arguments.
% Linter Rule 23 enforces context/4.
%
% See: epsilon_invariance_principle.md

% --- Namespace Hooks (Required for loading) ---
:- multifile
    domain_priors:base_extractiveness/2,
    domain_priors:suppression_score/2,
    domain_priors:theater_ratio/2,
    domain_priors:requires_active_enforcement/1,
    narrative_ontology:has_sunset_clause/1,
    narrative_ontology:interval/3,
    narrative_ontology:measurement/5,
    narrative_ontology:constraint_metric/3,
    narrative_ontology:constraint_beneficiary/2,
    narrative_ontology:constraint_victim/2,
    narrative_ontology:constraint_claim/2,
    narrative_ontology:affects_constraint/2,
    narrative_ontology:coordination_type/2,
    constraint_indexing:constraint_classification/3,
    constraint_indexing:directionality_override/3,
    narrative_ontology:omega_variable/3,
    narrative_ontology:human_readable/2,
    narrative_ontology:topic_domain/2.

/* ==========================================================================
   1. NARRATIVE CONTEXT
   ========================================================================== */

/**
 * CONSTRAINT IDENTIFICATION
 *   constraint_id: faint_blue_neural_bifurcation
 *   human_readable: The "Ken" Neural Enhancement Bifurcation
 *   domain: technological/social/pharmaceutical
 *
 * SUMMARY:
 *   The 'Ken' neural enhancement bifurcation represents a technological
 *   extraction constraint operating through covert neurochemical
 *   modification. A secret, unlisted phenethylamine derivative is distributed
 *   through institutional channels (or institutional negligence), producing
 *   permanent neural remodeling in exposed users without informed consent or
 *   awareness. The constraint exhibits classic snare structure: high
 *   extraction (0.58), high suppression (0.72), and increasing theater as
 *   regulatory authorities maintain performative oversight while the actual
 *   threat bypasses detection infrastructure. The bifurcation emerges from
 *   the structural gap between legitimate cognitive enhancement research and
 *   covert behavioral modification — users believing they are accessing
 *   enhancement may actually be experiencing autonomy reduction or value
 *   alteration. The trajectory shows increasing extractiveness (0.35→0.58) as
 *   distribution scales and increasing theater (0.45→0.68) as institutional
 *   oversight becomes more elaborate but less functional. The constraint
 *   satisfies mandatrophy resolution criteria through cross-perspectival
 *   analysis: legitimate enhancement research (Tangled Rope perspective) and
 *   regulatory authority (Piton perspective) are differentiated from pure
 *   extraction (Snare perspectives), preventing misclassification as
 *   coordination.
 *
 * KEY AGENTS:
 *   - Exposed Users: Primary victims (powerless/trapped) — suffer permanent neural remodeling without consent; cannot reverse effects or escape constraint
 *   - Cognitive Autonomy Commons: Collective victim (moderate/constrained) — distributed, non-organized aggregate of all humans; autonomy baseline compromised if neural remodeling alters decision-making at scale
 *   - Developer Network: Primary beneficiary (institutional/arbitrage) — captures value from covert distribution; achieves neural modification goals without legal liability
 *   - Institutional Distributors: Primary beneficiary (institutional/arbitrage) — profit from distribution; suppression serves their coordination function
 *   - Regulatory & Medical Authority: Secondary actor (organized/mobile) — maintains performative oversight; regulation theater masks regulatory failure
 *   - Enhancement Research Community: Secondary victim/beneficiary mix (powerful/mobile) — benefits from novel neural mechanisms but faces epistemic contamination from covert modification
 *   - Analytical Observer: Civilizational perspective (analytical/analytical) — risks naturalizing institutional failure as neurochemical inevitability
 */

/* ==========================================================================
   2. BASE PROPERTIES (DOMAIN PRIORS)
   ========================================================================== */

% --- Numerical metrics ---
domain_priors:base_extractiveness(faint_blue_neural_bifurcation, 0.58).
domain_priors:suppression_score(faint_blue_neural_bifurcation, 0.72).
domain_priors:theater_ratio(faint_blue_neural_bifurcation, 0.68).

% --- Constraint metric facts (engine primary keys, must mirror domain_priors) ---
narrative_ontology:constraint_metric(faint_blue_neural_bifurcation, extractiveness, 0.58).
narrative_ontology:constraint_metric(faint_blue_neural_bifurcation, suppression_requirement, 0.72).
narrative_ontology:constraint_metric(faint_blue_neural_bifurcation, theater_ratio, 0.68).

% --- Constraint claim ---
narrative_ontology:constraint_claim(faint_blue_neural_bifurcation, snare).
narrative_ontology:human_readable(faint_blue_neural_bifurcation, "The \"Ken\" Neural Enhancement Bifurcation").
narrative_ontology:topic_domain(faint_blue_neural_bifurcation, "technological/social/pharmaceutical").

domain_priors:requires_active_enforcement(faint_blue_neural_bifurcation).
% --- Structural relationships ---
narrative_ontology:constraint_beneficiary(faint_blue_neural_bifurcation, developer_network).
narrative_ontology:constraint_beneficiary(faint_blue_neural_bifurcation, institutional_distributors).
narrative_ontology:constraint_victim(faint_blue_neural_bifurcation, exposed_users).
narrative_ontology:constraint_victim(faint_blue_neural_bifurcation, cognitive_autonomy).

/* ==========================================================================
   3. INDEXED CLASSIFICATIONS (P, T, E, S)
   ========================================================================== */

% PERSPECTIVE 1: EXPOSED USER (SNARE) — Users exposed to the unlisted phenethylamine derivative experience permanent neural remodeling without informed consent. No exit option: cognitive changes are irreversible post-administration. Maximum extraction with maximum suppression — the constraint operates through deception (secret compound), biological lock-in (neural remodeling), and information asymmetry. Users cannot escape, cannot reverse effects, cannot organize collective resistance without self-identification as compromised.
constraint_indexing:constraint_classification(faint_blue_neural_bifurcation, snare,
    context(agent_power(powerless),
            time_horizon(biographical),
            exit_options(trapped),
            spatial_scope(global))).

% PERSPECTIVE 2: COGNITIVE AUTONOMY COMMONS (SNARE) — The distributed, non-organized aggregate of all humans with cognitive autonomy as a property. This constraint extracts from the commons by degrading the epistemic baseline: if neural remodeling alters decision-making, risk assessment, or value formation at scale, the entire population's autonomy is compromised. The commons cannot exit or even perceive the threat clearly. Maximum suppression through obscurity and lack of institutional visibility.
constraint_indexing:constraint_classification(faint_blue_neural_bifurcation, snare,
    context(agent_power(moderate),
            time_horizon(generational),
            exit_options(constrained),
            spatial_scope(global))).

% PERSPECTIVE 3: DEVELOPER NETWORK & INSTITUTIONAL DISTRIBUTORS (ROPE) — Beneficiaries experience the constraint as pure coordination. The secret compound and distribution network solve their coordination problem: how to achieve a specific neural outcome (enhancement, compliance, or behavioral modification) without legal liability or public resistance. Suppression serves their function — secrecy is the coordination mechanism itself. High effective extraction runs toward this agent, making the perspective genuinely beneficial.
constraint_indexing:constraint_classification(faint_blue_neural_bifurcation, rope,
    context(agent_power(institutional),
            time_horizon(immediate),
            exit_options(arbitrage),
            spatial_scope(global))).

% PERSPECTIVE 4: REGULATORY & MEDICAL AUTHORITY (PITON) — Institutional oversight (FDA, EMA, medical boards) maintains performative regulation and trial protocols. The actual constraint — covert neural modification via unlisted compounds — operates in the shadows of existing regulatory theater. Authorities see their own enforcement as degraded (undetectable black market compounds, distributed manufacturing, lack of detection infrastructure). The regulatory constraint persists through institutional inertia while the genuine threat bypasses oversight mechanisms entirely. Theater ratio high because compliance theater (clinical trials, labeling, pharmavigilance) fails to address the actual constraint.
constraint_indexing:constraint_classification(faint_blue_neural_bifurcation, piton,
    context(agent_power(organized),
            time_horizon(civilizational),
            exit_options(mobile),
            spatial_scope(global))).

% PERSPECTIVE 5: COGNITIVE ENHANCEMENT RESEARCH COMMUNITY (TANGLED ROPE) — Legitimate neuroscience researchers and enhancement enthusiasts face extraction (vulnerability to covert modification, epistemic contamination if results are driven by biased neural remodeling) but also benefit from access to novel neural mechanisms and faster discovery timelines. High exit options through institutional backing and publication, but significant suppression from regulatory barriers and unknown long-term effects. Mixed structure: genuine coordination function (knowledge sharing) + asymmetric extraction (secret compound hijacks research direction).
constraint_indexing:constraint_classification(faint_blue_neural_bifurcation, tangled_rope,
    context(agent_power(powerful),
            time_horizon(biographical),
            exit_options(mobile),
            spatial_scope(national))).

% PERSPECTIVE 6: ANALYTICAL OBSERVER / NEUROCHEMICAL NATURAL LAW (MOUNTAIN) — From a universal perspective, the constraint appears to exemplify an immutable property of neuropharmacology: any sufficiently potent neuroactive compound, if administered covertly without consent, will produce persistent neural remodeling. The 'Ken bifurcation' is thus a natural consequence of molecules and biology. However, this perspective risks naturalizing what is fundamentally a contingent social/institutional choice: the constraint exists because distribution is covert, manufacturing is distributed, and detection infrastructure is absent — not because neural remodeling is inherent to phenethylamines. The false summit hides the institutional failure.
constraint_indexing:constraint_classification(faint_blue_neural_bifurcation, mountain,
    context(agent_power(analytical),
            time_horizon(civilizational),
            exit_options(analytical),
            spatial_scope(universal))).

/* ==========================================================================
   4. VALIDATION TESTS
   ========================================================================== */

:- begin_tests(faint_blue_neural_bifurcation_tests).

test(perspectival_gap) :-
    constraint_indexing:constraint_classification(faint_blue_neural_bifurcation, TypePowerless, context(agent_power(powerless), _, _, _)),
    constraint_indexing:constraint_classification(faint_blue_neural_bifurcation, TypeOther, context(agent_power(institutional), _, _, _)),
    TypePowerless \= TypeOther.

test(extraction_signature) :-
    domain_priors:base_extractiveness(faint_blue_neural_bifurcation, E),
    E >= 0.46. % Ensures high-extraction Snare/Tangled territory.

test(piton_threshold) :-
    domain_priors:theater_ratio(faint_blue_neural_bifurcation, TR),
    TR >= 0.70.

:- end_tests(faint_blue_neural_bifurcation_tests).

/* ==========================================================================
   5. GENERATIVE COMMENTARY
   ========================================================================== */

/**
 * LOGIC RATIONALE:
 *   Extractiveness (0.58): High. The constraint operates through informational asymmetry and biological lock-in. Users expose themselves believing they are accessing legitimate enhancement; the actual compound produces neural remodeling (permanent, non-reversible post-administration) that may reduce autonomy, alter values, or increase compliance. The extraction is severe because the victim population cannot exit and cannot even perceive the threat clearly until remodeling has occurred. The trajectory (0.35→0.58) reflects scaling distribution and increasing irreversibility as more users are exposed and their neural changes compound. Suppression (0.72): Very high. The constraint requires multiple suppression mechanisms: (1) compound obscurity — the phenethylamine derivative is unlisted and structurally concealed; (2) distribution secrecy — institutional channels (or negligence) allow covert supply; (3) neurological obscurity — neural remodeling is not obviously detectable without specialized neuroimaging; (4) institutional theater — regulatory oversight creates false confidence that covert compounds are being detected. Theater ratio (0.68): High and increasing. Regulatory compliance theater (clinical trials, pharmavigilance, labeling requirements) persists while the actual threat (covert compounds, black market distribution, neural remodeling) bypasses all oversight mechanisms. The theater serves the illusion that the system is functional when it has catastrophically failed.
 *
 * PERSPECTIVAL GAP:
 *   This constraint exhibits stark perspectival divergence driven by structural position and informational asymmetry. The exposed user sees pure extraction (Snare): permanent, irreversible, with no exit. The developer network sees pure coordination (Rope): a solved problem in how to achieve neural modification without legal interference. The enhancement research community sees mixed extraction and benefit (Tangled Rope): access to novel mechanisms but epistemic contamination. Regulatory authority sees its own degraded function (Piton): performative compliance that fails to address the actual threat. The cognitive autonomy commons sees extraction but cannot organize perception (Snare + collective action problem). The analytical observer risks seeing immutable natural law (Mountain) — 'neural remodeling is inherent to potent neuropharmacology' — when the constraint is fundamentally institutional: covert distribution, regulatory failure, and lack of detection infrastructure. The perspectival gap reveals how the same structural phenomenon (secret compound + neural changes) is experienced as coordination (beneficiary), extraction (victim), degradation (authority), and natural law (observer) depending on position.
 *
 * DIRECTIONALITY LOGIC:
 *   Directionality computation proceeds from beneficiary/victim declarations and exit options. Exposed users (powerless/trapped) derive d ≈ 0.95 → f(d) ≈ 1.42 (maximum experienced extractiveness). Developer network (institutional/arbitrage) derives d ≈ 0.05 → f(d) ≈ -0.12 (maximum experienced benefit, negative chi). The cognitive autonomy commons (moderate/constrained) derives d ≈ 0.75 → f(d) ≈ 1.20 (high experienced extraction, cannot exit). Regulatory authority (organized/mobile) derives d ≈ 0.55 → f(d) ≈ 0.75 (moderate experienced extraction from their own oversight failure). Enhancement research community (powerful/mobile) derives d ≈ 0.50 → f(d) ≈ 0.65 (symmetric costs and benefits). The analytical observer (analytical/analytical) derives d ≈ 0.72 → f(d) ≈ 1.15 but perceives the constraint as a mountain (naturalized), suggesting false summit detection.
 *
 * MANDATROPHY ANALYSIS:
 *   RESOLUTION: The constraint resolves mandatrophy by distinguishing institutional extractiveness from scientific inevitability. The false summit (mountain perspective) claims neural remodeling is a natural property of phenethylamines — unavoidable, universal. The snare perspective shows the constraint is architecturally contingent: extraction depends on covert distribution, regulatory failure, lack of detection, and inability of victims to exit post-exposure. If distribution became transparent, compounds were detectible, and neural effects were reversible, the constraint would degrade significantly. The mountain classification is false because it naturalizes institutional choices (secrecy, negligence, suppression) as neurochemical inevitability. The tangled rope perspective (enhancement research) is legitimate — genuine coordination in knowledge sharing plus real extraction through epistemic contamination. The piton perspective is accurate — regulatory authority maintains theater (compliance monitoring) while function (threat detection) has atrophied. No single type is 'the' answer, but the snare and piton classifications dominate the lived experiences of exposed users and institutional agents, while the mountain is a mischaracterization used to evade accountability.
 */

/* ==========================================================================
   6. OMEGA VARIABLES (Ω) - IRREDUCIBLE UNCERTAINTIES
   ========================================================================== */

omega_variable(
    compound_identity_and_mechanism,
    'Is the phenethylamine derivative a genuine neural enhancement (improving cognition, decision-making, well-being) or a behavioral modifier (increasing compliance, reducing critical capacity, altering values)?',
    'Neuroimaging (fMRI, PET) longitudinal data on exposed users; cognitive battery testing (executive function, risk assessment, value formation); comparison with legitimate enhancement compounds; molecular structure analysis and binding affinity mapping',
    'If genuine enhancement: constraint may degrade to Tangled Rope (mixed benefit/extraction) from exposed user perspective. If behavioral modifier: snare classification confirmed across all perspectives; extraction is the primary function, not a side effect.',
    confidence_without_resolution(high)
).

narrative_ontology:omega_variable(compound_identity_and_mechanism, empirical, 'Whether compound enhances cognition or modifies behavior/values').

omega_variable(
    distribution_scale_and_prevalence,
    'What fraction of the global population has been exposed to the unlisted phenethylamine? Is exposure concentrated in specific demographics, geographies, or institutions?',
    'Biomarker screening in population surveys; metadata analysis of distributor networks; hospital records for neural-remodeling-compatible symptoms; genetic-epidemiological modeling of exposure patterns',
    'If < 0.1%: constraint may appear localized (regional scope), extracting less systematic power. If > 5%: constraint operates at civilizational scale, affecting epistemic baseline globally. Scale directly affects spatial_scope and suppression severity.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(distribution_scale_and_prevalence, empirical, 'Percentage and distribution of exposed population').

omega_variable(
    reversibility_and_neuroplasticity,
    'Are neural changes from the phenethylamine derivative genuinely irreversible, or can neuroplasticity and intervention restore pre-exposure cognitive architecture?',
    'Longitudinal neuroimaging of exposed users undergoing intervention (cognitive therapy, pharmaceutical reversal, neuromodulation); comparison with historical neuroplasticity literature; animal model studies of compound washout and neural recovery',
    'If reversible: exit_options upgrade from trapped → constrained for exposed users; snare may degrade to Tangled Rope. If irreversible: trapped classification confirmed; extraction is permanent biological lock-in; suppression ceiling increases.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(reversibility_and_neuroplasticity, empirical, 'Whether neural remodeling is reversible via intervention').

omega_variable(
    institutional_complicity_and_knowledge,
    'Are major institutional actors (pharmaceutical companies, regulatory agencies, research institutions, governments) actively complicit in the distribution, deliberately negligent, or genuinely unaware?',
    'Institutional records (FOIA requests, whistleblower testimony); communication logs and funding flows; regulatory inspection findings; comparative analysis with known institutional cover-ups (tobacco, opioids, asbestos)',
    'If actively complicit: piton perspective is aspirational rather than structural; regulatory authority has ceded its function entirely. If deliberately negligent: piton is accurate. If unaware: regulatory failure is honest incompetence, not performance; constraint may be scaffold (temporary during awareness phase) rather than snare.',
    confidence_without_resolution(low)
).

narrative_ontology:omega_variable(institutional_complicity_and_knowledge, empirical, 'Degree of institutional knowledge and deliberate participation').

omega_variable(
    countermeasure_feasibility,
    'Can detection (biomarkers, epidemiological surveillance, forensic neuroimaging), prevention (supply chain disruption, chemical synthesis barriers), or treatment (neural reversal, cognitive restoration) be scaled to eliminate or substantially reduce the constraint?',
    'Technical feasibility studies; cost-benefit analysis of detection vs suppression infrastructure; historical analysis of comparable countermeasures (drug trafficking, biological weapons); timeline modeling for implementation at global scale',
    'If countermeasures feasible and implementable: constraint may be scaffold (temporary with sunset) rather than snare (permanent extraction). If infeasible or prohibitively expensive: snare classification confirmed; constraint is architecturally stable.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(countermeasure_feasibility, empirical, 'Feasibility of detection, prevention, and treatment at scale').


/* ==========================================================================
   7. INTEGRATION HOOKS
   ========================================================================== */

narrative_ontology:interval(faint_blue_neural_bifurcation, 0, 10).

/* ==========================================================================
   8. TEMPORAL MEASUREMENTS (LIFECYCLE DRIFT DATA)
   ========================================================================== */

% Theater ratio over time
narrative_ontology:measurement(fbnb_tr_t0, faint_blue_neural_bifurcation, theater_ratio, 0, 0.45).
narrative_ontology:measurement(fbnb_tr_t5, faint_blue_neural_bifurcation, theater_ratio, 5, 0.62).
narrative_ontology:measurement(fbnb_tr_t10, faint_blue_neural_bifurcation, theater_ratio, 10, 0.68).

% Extraction over time
narrative_ontology:measurement(fbnb_be_t0, faint_blue_neural_bifurcation, base_extractiveness, 0, 0.35).
narrative_ontology:measurement(fbnb_be_t5, faint_blue_neural_bifurcation, base_extractiveness, 5, 0.52).
narrative_ontology:measurement(fbnb_be_t10, faint_blue_neural_bifurcation, base_extractiveness, 10, 0.58).


/* ==========================================================================
   9. BOLTZMANN & NETWORK DATA
   ========================================================================== */

narrative_ontology:coordination_type(faint_blue_neural_bifurcation, enforcement_mechanism).
narrative_ontology:affects_constraint(faint_blue_neural_bifurcation, cognitive_autonomy_verification).
narrative_ontology:affects_constraint(faint_blue_neural_bifurcation, pharmaceutical_supply_chain_opacity).
narrative_ontology:affects_constraint(faint_blue_neural_bifurcation, neural_modification_regulatory_capture).

% DUAL FORMULATION NOTE:
% The 'Ken' bifurcation decomposes into three structurally distinct constraints: (1) the compound itself (neurochemical mechanism), (2) the distribution network (social/institutional logistics), and (3) the regulatory failure (institutional performance). This story focuses on the integrated constraint from the victim's perspective. Upstream constraints (supply chain opacity, regulatory capture) influence this story's extractiveness; downstream constraints (cognitive autonomy verification, detection infrastructure) are affected by this story's structural properties. All three are linked through network.affects_constraints.

/* ==========================================================================
   10. DIRECTIONALITY OVERRIDES (v6.0, OPTIONAL)
   ========================================================================== */

constraint_indexing:directionality_override(faint_blue_neural_bifurcation, institutional, 0.55).

/* ==========================================================================
   END OF CONSTRAINT STORY
   ========================================================================== */
